Similarly, in Parkinson’s disease, the degradation of alpha-synuclein via CMA is critical for preventing its aggregation, which is implicated in the formation of Lewy bodies and subsequent neurodegeneration. This evidence concerns the gene SNCA and Parkinson disease.